Sangamo Therapeutics, Inc.
Methods and compositions for modulating PD1
Last updated:
Abstract:
Disclosed herein are methods and compositions for modulating expression of a PD1 gene.
Status:
Grant
Type:
Utility
Filling date:
12 Jul 2018
Issue date:
1 Feb 2022